Janeen Doyle
Förmögenhet: 1 M $ per 2026-07-31
Förmögenhet: 1 M $ per 2026-07-31
Ms. Janeen Doyle is a Chief Corporate & Business Development Officer at Janux Therapeutics, Inc. Ms. Doyle was previously employed as a Senior VP-Strategy & Business Development by Bristol Myers Squibb Co. and a Senior VP-Strategy & Business Development by Celgene Corp.
She received her undergraduate degree from Moravian College and an MBA from the University of Scranton.
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
JANUX THERAPEUTICS, INC. 0,13 % | 2026-06-02 | 75 941 ( 0,13 % ) | 1 M $ | 2026-07-31 |
| Företag | Position | Start |
|---|---|---|
| JANUX THERAPEUTICS, INC. | Företagsledare/Principal | 2025-05-15 |
| Företag | Position | Slut |
|---|---|---|
| CELGENE | Företagsledare/Principal | - |
| BRISTOL-MYERS SQUIBB COMPANY | Företagsledare/Principal | - |
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
| Privata företag | 5 |
|---|---|
Bristol Myers Squibb Co.
Bristol Myers Squibb Co. Pharmaceuticals: MajorHealth Technology Manufactures and markets biopharmaceuticals products | Health Technology |
Celgene Corp.
Celgene Corp. BiotechnologyHealth Technology Develops cancer and immunology drugs | Health Technology |
Moravian College
Moravian College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Scranton
University of Scranton Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Janux Therapeutics, Inc.
Janux Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage company that develops precision engineered immunotherapies | Health Technology |
Välj din utgåva
All finansiell information anpassad till den nationella nivån